Combination immunotherapy treatment significantly improves disease-free survival following surgery in patients with the most common type of kidney cancer, according to new research. Results from the ...

Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

Image: DNA sequence. Credit: The Institute of Cancer Research, London. A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for one ...

Twenty years ago today, the International Genome Sequencing Consortium published the first detailed analysis of the human genome. The paper appeared online in Nature on 15 February 2001, followed by a ...

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...

Black men are more likely than their White or Asian counterparts to have a range of genetic changes that increase their risk of developing prostate cancer, a major new study reports. The genetic ...

Scientists have shown for the first time that some of the most persistent cancer cells in glioblastoma, a common type of adult brain tumour, rely on a specific enzyme for survival and that inhibiting ...

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

Image: Person walking towards the beach. Credits: Pixabay. Most people are aware of the benefits of exercise – it has been associated with improvements in overall health for some time. It makes sense ...

A new study has provided novel insights into the effects of radiation on the immune cells surrounding breast cancer tumours. The findings show that the relationship between these cells, known as the ...

The last decade has brought major advances in the way we diagnose and treat prostate cancer and men with advanced disease are living longer than ever. Diana Cano spoke to our scientists about the most ...